1 Market Overview
1.1 Niraparib Introduction
1.2 Market Analysis by Type
1.2.1 100mg*30 Capsules
1.2.2 100mg*60 Capsules
1.2.3 100mg*90 Capsules
1.3 Market Analysis by Applications
1.3.1 Recurrent Epithelial Ovarian Cancer
1.3.2 Fallopian Tube Cancer
1.3.3 Primary Peritoneal Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 TESARO
2.1.1 Business Overview
2.1.2 Niraparib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 TESARO Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Everest Pharmaceuticals Limited
2.2.1 Business Overview
2.2.2 Niraparib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Niraparib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Niraparib Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Niraparib Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Niraparib Manufacturer Market Share in 2019
3.3.2 Top 6 Niraparib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Niraparib Market Analysis by Regions
4.1 Global Niraparib Sales, Revenue and Market Share by Regions
4.1.1 Global Niraparib Sales and Market Share by Regions (2015-2019)
4.1.2 Global Niraparib Revenue and Market Share by Regions (2015-2019)
4.2 North America Niraparib Sales and Growth Rate (2015-2019)
4.3 Europe Niraparib Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Niraparib Sales and Growth Rate (2015-2019)
4.5 South America Niraparib Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Niraparib Sales and Growth Rate (2015-2019)
5 North America Niraparib by Country
5.1 North America Niraparib Sales, Revenue and Market Share by Country
5.1.1 North America Niraparib Sales and Market Share by Country (2015-2019)
5.1.2 North America Niraparib Revenue and Market Share by Country (2015-2019)
5.2 United States Niraparib Sales and Growth Rate (2015-2019)
5.3 Canada Niraparib Sales and Growth Rate (2015-2019)
5.4 Mexico Niraparib Sales and Growth Rate (2015-2019)
6 Europe Niraparib by Country
6.1 Europe Niraparib Sales, Revenue and Market Share by Country
6.1.1 Europe Niraparib Sales and Market Share by Country (2015-2019)
6.1.2 Europe Niraparib Revenue and Market Share by Country (2015-2019)
6.2 Germany Niraparib Sales and Growth Rate (2015-2019)
6.3 UK Niraparib Sales and Growth Rate (2015-2019)
6.4 France Niraparib Sales and Growth Rate (2015-2019)
6.5 Russia Niraparib Sales and Growth Rate (2015-2019)
6.6 Italy Niraparib Sales and Growth Rate (2015-2019)
7 Asia-Pacific Niraparib by Country
7.1 Asia-Pacific Niraparib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Niraparib Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Niraparib Revenue and Market Share by Country (2015-2019)
7.2 China Niraparib Sales and Growth Rate (2015-2019)
7.3 Japan Niraparib Sales and Growth Rate (2015-2019)
7.4 Korea Niraparib Sales and Growth Rate (2015-2019)
7.5 India Niraparib Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Niraparib Sales and Growth Rate (2015-2019)
8 South America Niraparib by Country
8.1 South America Niraparib Sales, Revenue and Market Share by Country
8.1.1 South America Niraparib Sales and Market Share by Country (2015-2019)
8.1.2 South America Niraparib Revenue and Market Share by Country (2015-2019)
8.2 Brazil Niraparib Sales and Growth Rate (2015-2019)
8.3 Argentina Niraparib Sales and Growth Rate (2015-2019)
8.4 Colombia Niraparib Sales and Growth Rate (2015-2019)
9 Middle East and Africa Niraparib by Countries
9.1 Middle East and Africa Niraparib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Niraparib Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Niraparib Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Niraparib Sales and Growth Rate (2015-2019)
9.3 Turkey Niraparib Sales and Growth Rate (2015-2019)
9.4 Egypt Niraparib Sales and Growth Rate (2015-2019)
9.5 Nigeria Niraparib Sales and Growth Rate (2015-2019)
9.6 South Africa Niraparib Sales and Growth Rate (2015-2019)
10 Global Niraparib Market Segment by Type
10.1 Global Niraparib Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Niraparib Sales and Market Share by Type (2015-2019)
10.1.2 Global Niraparib Revenue and Market Share by Type (2015-2019)
10.2 100mg*30 Capsules Sales Growth and Price
10.2.1 Global 100mg*30 Capsules Sales Growth (2015-2019)
10.2.2 Global 100mg*30 Capsules Price (2015-2019)
10.3 100mg*60 Capsules Sales Growth and Price
10.3.1 Global 100mg*60 Capsules Sales Growth (2015-2019)
10.3.2 Global 100mg*60 Capsules Price (2015-2019)
10.4 100mg*90 Capsules Sales Growth and Price
10.4.1 Global 100mg*90 Capsules Sales Growth (2015-2019)
10.4.2 Global 100mg*90 Capsules Price (2015-2019)
11 Global Niraparib Market Segment by Application
11.1 Global Niraparib Sales Market Share by Application (2015-2019)
11.2 Recurrent Epithelial Ovarian Cancer Sales Growth (2015-2019)
11.3 Fallopian Tube Cancer Sales Growth (2015-2019)
11.4 Primary Peritoneal Cancer Sales Growth (2015-2019)
11.5 Other Sales Growth (2015-2019)
12 Niraparib Market Forecast (2020-2025)
12.1 Global Niraparib Sales, Revenue and Growth Rate (2020-2025)
12.2 Niraparib Market Forecast by Regions (2020-2025)
12.2.1 North America Niraparib Market Forecast (2020-2025)
12.2.2 Europe Niraparib Market Forecast (2020-2025)
12.2.3 Asia-Pacific Niraparib Market Forecast (2020-2025)
12.2.4 South America Niraparib Market Forecast (2020-2025)
12.2.5 Middle East and Africa Niraparib Market Forecast (2020-2025)
12.3 Niraparib Market Forecast by Type (2020-2025)
12.3.1 Global Niraparib Sales Forecast by Type (2020-2025)
12.3.2 Global Niraparib Market Share Forecast by Type (2020-2025)
12.4 Niraparib Market Forecast by Application (2020-2025)
12.4.1 Global Niraparib Sales Forecast by Application (2020-2025)
12.4.2 Global Niraparib Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
